New Partnership will advance three antibacterial programmes as part of the Innovative Medicines Initiative (IMI), a public-private European R&D consortium. The new GNA NOW project, led by Evotec SE and managed by Lygature, will work on the development of novel antibacterial agents to battle antimicrobial resistance in gram-negative bacteria. Fraunhofer IME is one of the 11 beneficiaries.more info
© Fraunhofer IME | Ruth Hausmann
Find here our Annual Reports, Booklets and Flyers, Scientific Publications, Software, Movies as well as Product Sheets and Technology Offers.